• Vaxcyte Chief Operating Officer Jim Wassil exercised options for 516 shares at USD 5.35 on July 1, 2026.
• Wassil sold 2,250 shares on July 1 at prices around USD 56.03 to USD 57.82.
• Directly held common stock ended the day at 156,760 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001813798-26-000013), on July 06, 2026, and is solely responsible for the information contained therein.